Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
- PMID: 18675683
- DOI: 10.1016/S0140-6736(08)61153-8
Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
Comment on
-
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.Lancet. 2008 Mar 29;371(9618):1073-84. doi: 10.1016/S0140-6736(08)60485-7. Lancet. 2008. PMID: 18374840 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
